PregnancyNCT00505869
A Mood Management Intervention for Pregnant Smokers
An observational study of Pregnancy and Smoking, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
This proposal is aimed at testing the following hypotheses: 1. Cessation rates will be significantly greater for smokers in a mood management condition versus a health \& wellness condition during pregnancy and at 3 and 6 months postpartum. 2. Read more about this study
- Who is it for?
- Ages 16 years and older, women only
- What is being tested?
- Health & Wellness Intervention, Questionnaire and Mood Management Intervention
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 338 participants
- Where
- 1 siteUnited States
- Study dates
- Aug 2004to Apr 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients who are pregnant smokers who may be under stress.
Who may be able to join
- Gestation: < or = 32 weeks pregnant at baseline
- Age: 16 years or older
- Smoking: at least a puff of a cigarette in the past 7 days \& willing to set quit date that occurs before the end of treatment.
- English speaking \& have a telephone
- Willing to attend all sessions and have no known complications that would adversely affect attendance
- Other: provide informed consent \& agree to all assessments \& study procedures
Who cannot join
- Current psychotherapy
- Involvement within one day of telephone screen with any smoking cessation activities other than those that are freely available in the public domain.
- History of/current medical condition, or any other factor, that, in the judgment of the Principal Investigator, would likely preclude completion of study requirements.
Trial locations and contacts
1 site in 1 country.
United States1 site
U.T.M.D. Anderson Cancer Center
Houston, Texas, 77030
About this study
This proposal is aimed at testing the following hypotheses:
- Cessation rates will be significantly greater for smokers in a mood management condition versus a health \& wellness condition during pregnancy and at 3 and 6 months postpartum.
- Pregnant smokers who have a higher level of depressive symptomatology will quit significantly less often in the health \& wellness condition vs. mood management condition; those with a lower level of depressive symptomatology will not demonstrate this treatment difference.
- Pregnant smokers who show higher levels of current depression at the start of the intervention will quit significantly less often than those smokers with lower levels.
The mood management intervention will result in higher levels of adaptive coping behavior, self-efficacy, social support, and perceived support from the counselor, and lower levels of negative affect, rumination, and perceived stress, than the health \& wellness intervention and these variables will be related to abstinence. Thus, we will evaluate the effects of the intervention (health \& wellness and mood management) on hypothesized treatment mechanisms, and assess the impact of those mechanisms on abstinence.
Read the detailed description
Before treatment begins, you will have a screening visit with the study doctor/staff, to find out if you are eligible to take part in the study. This visit will involve an in-depth interview about your history of depression and other mental health problems. If you have not yet been to a doctor, the study staff will give you a urine pregnancy test to make sure you are pregnant.You will also be asked to complete several questionnaires regarding smoking history and other areas of your daily life. The questionnaires themselves take about 30-45 minutes to complete. The visit may last between 1 1/2 and 3 1/2 hours, depending on the complexity of the interview.
If you are eligible to take part in the study, you will receive one of two types of smoking cessation counseling. In one, counseling will focus on health concerns related to pregnancy, information about smoking and pregnancy, tips for quitting, and problem-solving skills to manage situations that might be triggers for smoking. In the other, counseling will focus on the learning to manage negative moods (depressed mood, tension, anxiety), as well as providing tips for quitting smoking, problem-solving skills, and information about smoking and pregnancy. Counseling sessions for both groups will last about an hour each.
During the first counseling visit, you will set a quit date for stopping smoking.
At each of the counseling visits, you will also be asked to provide a carbon monoxide (CO) measurement. This is done by blowing into a cardboard tube attached to a CO monitor. This will show whether or not you are still smoking. You will also complete several questionnaires at every visit, which will take about 20-40 minutes. These questionnaires will include questions about your mood, confidence in quitting, smoking behavior, and social support.
Four times during the study, you will provide a saliva sample for tests to look for cotinine, a chemical produced by the breakdown of nicotine during smoking. This sample will be taken using a dental roll (cotton swab) placed in the mouth for several minutes to absorb saliva. Like the CO test, this test will help researchers measure how much you are smoking.
You will be asked to attend a maximum of 12 individual counseling sessions, over a 2-3 month period. Also, you will receive 4 follow-up telephone calls from the study staff. These calls will take place 2 weeks after treatment ends, 2 weeks before your due date, 2 weeks after your delivery, and 4 weeks after your delivery.
Additional in-person clinic visits will take place at 3- and 6-months after your delivery. During these visits you will be asked to provide carbon monoxide (CO) and cotinine measurements of your smoking and to complete a packet of questionnaires regarding your mood, social support, and smoking behavior.
So that the study researchers can keep in contact with you throughout the study and over the long period of time between your end of treatment visit and the 3- and 6-month postpartum follow-up visits, you will be asked at the baseline visit to provide the name and address of 3 contacts (family members/friends) that you feel confident would have updated contact information on you. You will also be asked to sign a letter giving your contacts permission to provide your updated information to the study staff. The staff will check this contact information at the end-of-treatment visit, at one of the telephone assessment calls and then again at the 3-month follow-up visit.
If the study staff is not able to reach you by phone, mail, or the information provided by your contacts, they may attempt to locate you through telephone directory assistance (411) or internet search sources (for example, Google or Yahoo!), which use information from the public domain (meaning everyone has access to it).
If the study staff is still unable to locate your new contact information, they may use a locator service such as Transunion or the National Change of Address (NCOA) database maintained by the United States Postal Service, as a last resort. Transunion uses things like magazine subscriptions and credit applications to find new addresses, and the NCOA uses the Change of Address cards filed with the post office when a person moves and requests their mail be forwarded to a new address. If the study staff has to use either of these services, they would only disclose your name and last known address.
Researchers may also use Temporary Assistance for Needy Families (Welfare)/Medicaid Administrative databases, maintained by the Texas Department of Human Services (TDHS), to find contact information for participants who cannot be found for follow-up study. The study staff will provide designated Welfare personnel with a list containing the name, date of birth, last known address, and other relevant personal identifiers for each of the participants with whom we cannot contact. In return, Welfare personnel will provide study staff with the most recent locator information (such as address and phone numbers) for each of the listed participants.
Under certain circumstances, your counselor may provide counseling to you over the phone. Additionally, you may be mailed some questionnaires and/or a cotinine sample kit. If so, a pre-addressed, postage paid envelope will be provided for the return of these materials.
Each of the counseling sessions will be videotaped. In addition, the SCID assessment done at the Baseline visit and the LIFE Assessment done at both follow-up visits, may be videotaped or audiotaped to make sure you are being rated correctly. The videotapes, will be erased within one year following your completion of the study. The videotapes will be used to help the investigators make sure that the counselors are following the correct procedures and may be used in future studies to help the investigators better understand the mood management and behavioral counseling treatments. No one but the study investigators or those delegated by the study investigators will be allowed to view the tapes and the identity of the participants will be kept strictly confidential. Staff that may be given permission by the study investigators to view the tapes include project staff, consultants that review and rate how well the study therapists giving the intervention follow study guidelines, and/or consultants that review how the assessments are given.
This is an investigational study. Up to 450 women will take part in this study. All will be enrolled at M. D. Anderson.
- Being tested
- Health & Wellness Intervention, Questionnaire, Mood Management Intervention
- Keywords
- Pregnant Smokers, Mood Management Intervention, Health & Wellness Intervention, Smoking Cessation, Questionnaire, Survey
- Medical subject headings
- Smoking, Smoking Cessation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Health & Wellness InterventionBehavioural
Counseling focusing on health concerns related to pregnancy, information about smoking and pregnancy, tips for quitting, and problem-solving skills to manage situations that might be triggers for smoking.
QuestionnaireBehavioural
Also called Survey
Questionnaires about mood, confidence in quitting, smoking behavior, and social support.
Mood Management InterventionBehavioural
Counseling focusing on learning to manage negative moods (depressed mood, tension, anxiety), as well as providing tips for quitting smoking, problem-solving skills, and information about smoking and pregnancy.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Health \& Wellness Intervention + Questionnaire Receives: Behavioral: Health & Wellness Intervention; Behavioral: Questionnaire | |
| 2 | Mood Management Intervention + Questionnaire Receives: Behavioral: Questionnaire; Behavioral: Mood Management Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Patients with Prolonged Abstinence
Prolonged abstinence assessed following treatment through 6 months postpartum to test effectiveness of health education versus a mood management treatment for helping pregnant women quit smoking.
Measured: 3 month assessments from end of treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jul 2007 (estimated)
- Study startAug 2004
- Primary completionApr 2010
- Study completionApr 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PregnancyStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 338 participants (actual)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Responsible party
- Sponsor
- Investigators
- Paul Cinciripini, PhD, Principal investigator, M.D. Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00505869
- Sponsor's protocol ID
- 2004-0022
- Status last verified
- Aug 2012
- First submitted
- 23 Jul 2007
- Last updated
- 2 Aug 2012
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 2 Aug 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Mood Management Intervention for Pregnant Smokers
- ClinicalTrials.gov ID
- NCT00505869
- Acronym / sponsor ID
- 2004-0022
- Keywords
- Pregnant Smokers, Mood Management Intervention, Health & Wellness Intervention, Smoking Cessation, Questionnaire, Survey
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 338 participants (actual)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Study start
- Aug 2004
- Primary completion
- Apr 2010 (actual)
- Study completion
- Apr 2010 (actual)
- First posted
- 25 Jul 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This proposal is aimed at testing the following hypotheses:
- Cessation rates will be significantly greater for smokers in a mood management condition versus a health \& wellness condition during pregnancy and at 3 and 6 months postpartum.
- Pregnant smokers who have a higher level of depressive symptomatology will quit significantly less often in the health \& wellness condition vs. mood management condition; those with a lower level of depressive symptomatology will not demonstrate this treatment difference.
- Pregnant smokers who show higher levels of current depression at the start of the intervention will quit significantly less often than those smokers with lower levels.
The mood management intervention will result in higher levels of adaptive coping behavior, self-efficacy, social support, and perceived support from the counselor, and lower levels of negative affect, rumination, and perceived stress, than the health \& wellness intervention and these variables will be related to abstinence. Thus, we will evaluate the effects of the intervention (health \& wellness and mood management) on hypothesized treatment mechanisms, and assess the impact of those mechanisms on abstinence.
Detailed description
Before treatment begins, you will have a screening visit with the study doctor/staff, to find out if you are eligible to take part in the study. This visit will involve an in-depth interview about your history of depression and other mental health problems. If you have not yet been to a doctor, the study staff will give you a urine pregnancy test to make sure you are pregnant.You will also be asked to complete several questionnaires regarding smoking history and other areas of your daily life. The questionnaires themselves take about 30-45 minutes to complete. The visit may last between 1 1/2 and 3 1/2 hours, depending on the complexity of the interview.
If you are eligible to take part in the study, you will receive one of two types of smoking cessation counseling. In one, counseling will focus on health concerns related to pregnancy, information about smoking and pregnancy, tips for quitting, and problem-solving skills to manage situations that might be triggers for smoking. In the other, counseling will focus on the learning to manage negative moods (depressed mood, tension, anxiety), as well as providing tips for quitting smoking, problem-solving skills, and information about smoking and pregnancy. Counseling sessions for both groups will last about an hour each.
During the first counseling visit, you will set a quit date for stopping smoking.
At each of the counseling visits, you will also be asked to provide a carbon monoxide (CO) measurement. This is done by blowing into a cardboard tube attached to a CO monitor. This will show whether or not you are still smoking. You will also complete several questionnaires at every visit, which will take about 20-40 minutes. These questionnaires will include questions about your mood, confidence in quitting, smoking behavior, and social support.
Four times during the study, you will provide a saliva sample for tests to look for cotinine, a chemical produced by the breakdown of nicotine during smoking. This sample will be taken using a dental roll (cotton swab) placed in the mouth for several minutes to absorb saliva. Like the CO test, this test will help researchers measure how much you are smoking.
You will be asked to attend a maximum of 12 individual counseling sessions, over a 2-3 month period. Also, you will receive 4 follow-up telephone calls from the study staff. These calls will take place 2 weeks after treatment ends, 2 weeks before your due date, 2 weeks after your delivery, and 4 weeks after your delivery.
Additional in-person clinic visits will take place at 3- and 6-months after your delivery. During these visits you will be asked to provide carbon monoxide (CO) and cotinine measurements of your smoking and to complete a packet of questionnaires regarding your mood, social support, and smoking behavior.
So that the study researchers can keep in contact with you throughout the study and over the long period of time between your end of treatment visit and the 3- and 6-month postpartum follow-up visits, you will be asked at the baseline visit to provide the name and address of 3 contacts (family members/friends) that you feel confident would have updated contact information on you. You will also be asked to sign a letter giving your contacts permission to provide your updated information to the study staff. The staff will check this contact information at the end-of-treatment visit, at one of the telephone assessment calls and then again at the 3-month follow-up visit.
If the study staff is not able to reach you by phone, mail, or the information provided by your contacts, they may attempt to locate you through telephone directory assistance (411) or internet search sources (for example, Google or Yahoo!), which use information from the public domain (meaning everyone has access to it).
If the study staff is still unable to locate your new contact information, they may use a locator service such as Transunion or the National Change of Address (NCOA) database maintained by the United States Postal Service, as a last resort. Transunion uses things like magazine subscriptions and credit applications to find new addresses, and the NCOA uses the Change of Address cards filed with the post office when a person moves and requests their mail be forwarded to a new address. If the study staff has to use either of these services, they would only disclose your name and last known address.
Researchers may also use Temporary Assistance for Needy Families (Welfare)/Medicaid Administrative databases, maintained by the Texas Department of Human Services (TDHS), to find contact information for participants who cannot be found for follow-up study. The study staff will provide designated Welfare personnel with a list containing the name, date of birth, last known address, and other relevant personal identifiers for each of the participants with whom we cannot contact. In return, Welfare personnel will provide study staff with the most recent locator information (such as address and phone numbers) for each of the listed participants.
Under certain circumstances, your counselor may provide counseling to you over the phone. Additionally, you may be mailed some questionnaires and/or a cotinine sample kit. If so, a pre-addressed, postage paid envelope will be provided for the return of these materials.
Each of the counseling sessions will be videotaped. In addition, the SCID assessment done at the Baseline visit and the LIFE Assessment done at both follow-up visits, may be videotaped or audiotaped to make sure you are being rated correctly. The videotapes, will be erased within one year following your completion of the study. The videotapes will be used to help the investigators make sure that the counselors are following the correct procedures and may be used in future studies to help the investigators better understand the mood management and behavioral counseling treatments. No one but the study investigators or those delegated by the study investigators will be allowed to view the tapes and the identity of the participants will be kept strictly confidential. Staff that may be given permission by the study investigators to view the tapes include project staff, consultants that review and rate how well the study therapists giving the intervention follow study guidelines, and/or consultants that review how the assessments are given.
This is an investigational study. Up to 450 women will take part in this study. All will be enrolled at M. D. Anderson.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 1 | – | Behavioral: Health & Wellness Intervention, Behavioral: QuestionnaireHealth \& Wellness Intervention + Questionnaire |
| 2 | – | Behavioral: Questionnaire, Behavioral: Mood Management InterventionMood Management Intervention + Questionnaire |
Who may qualify
- Ages
- 16 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients who are pregnant smokers who may be under stress.
Key inclusion criteria (6 listed)
- Gestation: < or = 32 weeks pregnant at baseline
- Age: 16 years or older
- Smoking: at least a puff of a cigarette in the past 7 days \& willing to set quit date that occurs before the end of treatment.
- English speaking \& have a telephone
- Willing to attend all sessions and have no known complications that would adversely affect attendance
Key exclusion criteria (3 listed)
- Current psychotherapy
- Involvement within one day of telephone screen with any smoking cessation activities other than those that are freely available in the public domain.
- History of/current medical condition, or any other factor, that, in the judgment of the Principal Investigator, would likely preclude completion of study requirements.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Health & Wellness InterventionCounseling focusing on health concerns related to pregnancy, information about smoking and pregnancy, tips for quitting, and problem-solving skills to manage situations that might be triggers for smoking. | Behavioural | 1 |
| QuestionnaireAlso: SurveyQuestionnaires about mood, confidence in quitting, smoking behavior, and social support. | Behavioural | 1, 2 |
| Mood Management InterventionCounseling focusing on learning to manage negative moods (depressed mood, tension, anxiety), as well as providing tips for quitting smoking, problem-solving skills, and information about smoking and pregnancy. | Behavioural | 2 |
Primary outcome
Number of Patients with Prolonged Abstinence
Time frame: 3 month assessments from end of treatment
Prolonged abstinence assessed following treatment through 6 months postpartum to test effectiveness of health education versus a mood management treatment for helping pregnant women quit smoking.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Aug 2012.
- UT MD Anderson Cancer CenterLink provided by the sponsor.
Related trials for Pregnancy
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Paul Cinciripini, PhD principal investigator
M.D. Anderson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pregnancy and Smoking, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Aug 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of Patients with Prolonged Abstinence (time frame: 3 month assessments from end of treatment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2012.